Article Contents ::
- 1 Details About Generic Salt :: Indapami
- 2 Main Medicine Class:: Thiazide diuretic
- 3 (IN-DAP-uh-mide) Lozol, Apo-Indapamide, Novo-Indapamide, Nu-Indapamide Class: Thiazide diuretic
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Indapami
Main Medicine Class:: Thiazide diuretic
(IN-DAP-uh-mide)
Lozol, Apo-Indapamide, Novo-Indapamide, Nu-Indapamide
Class: Thiazide diuretic
Drugs Class ::
Action Enhances excretion of sodium, chloride, and water by interfering with transport of sodium ions across renal tubular epithelium.
Indications for Drugs ::
Indications Treatment of edema associated with CHF, hepatic cirrhosis, renal dysfunction, and corticosteroid or estrogen therapy; management of hypertension. Unlabeled use(s): Treatment of calcium nephrolithiasis, osteoporosis, or diabetes insipidus.
Drug Dose ::
Route/Dosage
ADULTS: PO 1.25 to 5 mg q morning. Maximum 5 mg/day.
Contraindication ::
Contraindications Hypersensitivity to thiazides, related diuretics, or sulfonamide-derived drugs; anuria.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: May be excreted in breast milk. Hypersensitivity: May occur in patients with or without history of allergy or bronchial asthma; cross-sensitivity with sulfonamides may also occur. Electrolyte balance: Severe hyponatremia and hypokalemia may infrequently occur with recommended doses; more common in elderly females. Hepatic impairment: Minor alterations of fluid and electrolyte balance may precipitate hepatic coma; use with caution. Lipids: May cause increased concentrations of total triglycerides and LDL in some patients. Lupus erythematosus: Exacerbation or activation may occur. Postsympathectomy patients: Antihypertensive effects may be enhanced. Renal impairment: May precipitate azotemia; use with caution.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Orthostatic hypotension; palpitations. CNS: Dizziness; lightheadedness; vertigo; headache; weakness; restlessness; insomnia; drowsiness; fatigue; lethargy; anxiety; depression; nervousness. DERM: Rash; necrotizing angiitis; vasculitis; cutaneous vasculitis; pruritus. EENT: Blurred vision. GI: Anorexia; gastric irritation; epigastric distress; nausea; vomiting; abdominal pain/cramping/bloating; diarrhea; constipation; dry mouth. GU: Nocturia; impotence/reduced libido. HEMA: Neutropenia. META: Hyperglycemia; glycosuria; hyperuricemia. RESP: Rhinorrhea. OTHER: Muscle cramp or spasm; acute gout.
Drug Mode of Action ::
Action Enhances excretion of sodium, chloride, and water by interfering with transport of sodium ions across renal tubular epithelium.
Drug Interactions ::
Interactions
Bile acid sequestrants: May reduce thiazide absorption; give thiazide ³ 2 hr before resin. Diazoxide: Hyperglycemia may occur. Digitalis glycosides: Diuretic-induced hypokalemia and hypomagnesemia may precipitate digitalis-induced arrhythmias. Lithium: May decrease renal excretion of lithium; monitor lithium levels. Loop diuretics: May result in synergistic effects and result in profound diuresis and serious electrolyte abnormalities. Sulfonylureas, insulin: May decrease hypoglycemic effect of sulfonylureas. May need to adjust dosage of sulfonylureas or insulin.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Weigh patient daily.
- Assess feet, legs, and sacral area for edema daily.
- Measure I&O throughout therapy.
- Monitor BP, with patient lying and standing.
- Monitor renal function (nonprotein nitrogen, BUN, creatinine, glomerular filtration) and serum potassium, sodium, calcium, magnesium, blood pH, and uric acid as ordered.
- Assess for signs of metabolic alkalosis and hypokalemia.
- Report to physician signs of renal dysfunction (eg, anuria, oliguria); liver dysfunction (eg, dark urine, jaundice, pruritus); gout (eg, rising serum uric acid, joint pain); muscle weakness; cramps, nausea; dizziness; numbness; irregular heartbeat; irritability.
|
Drug Storage/Management ::
Administration/Storage
- Administer as morning dose to prevent nocturia.
- Give with food or milk if nausea occurs.
- Store in tightly closed, light-resistant container at room temperature.
Drug Notes ::
Patient/Family Education
- Tell patient to take medication early in day to prevent sleep problems.
- Instruct patient to take drug with food or milk to minimize GI irritation.
- Caution patient to avoid exposure to sunlight and to use sunscreen or wear protective clothing to avoid photosensitivity reaction.
- Instruct patients with diabetes to report increased blood glucose levels.
- Caution patients to avoid sudden position changes to prevent orthostatic hypotension.
- Advise patients to include in diet foods that are high in potassium (eg, bananas, broccoli, dried fruits, grapefruit, lima beans, nuts, oranges).
- Tell patient to report decrease in urinary output, jaundice, muscle cramps, weakness, nausea, blurred vision, or dizziness.
- For patients being treated for hypertension, explain benefits of weight reduction, exercise, reduction of alcohol and sodium intake, cessation of smoking.